DEZELBY
Live / Allowed — Approved for publication (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79454223
- Mark type
- Stylized text
- Filed
- 05 May 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Novartis AG, CH
Prosecution history
- 08 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2026 — ASSIGNED TO EXAMINER
- 02 Sept 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 02 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Aug 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 16 Jul 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB